Anonymous
Guest
Anonymous
Guest
In the next 6 months any predictions as to what will be happening with B+L?
Another CEO if top line performance continues to lag. Rumors already swirling as to who's on the short list.
Who is on the short list?
Who is on the short list?
Who is on the short list?
At least one insider is jockeying for the role. He's had his eye on it since he joined as a Warburg installed executive.
Who is on the short list?
Why don't they just sell this thing? Then they do not have to worry about getting a new CEO.
They cannot find anyone dumb enough to buy it.
I was told that the new products that have been launched in the last year and a half from Pharma, Vision Care and Surgical are really doing well in the marketplace.
you were told huh?
Pharm products are a joke. Ask any eye doc anywhere, what their current view point of any B&L product is and they will laugh.
They're eye drops. There are better generic equivalents available in all classes for half of the price. That includes zirgan too, but the volume is so low it's not even worth discussing.
Vision care is getting its ass kicked. Crystalens is dying the death of a thousand cuts. The whole company is.
products are a joke, management is a disaster, Rep turnover has crushed the sales force, and the result is that the company is in real trouble. Can't survive in this economy. Someone will take it, in whole or in parts. Bet on it.
Are you sure??? There was a lot of hype around the product releases as next generation innovations that were to give us an edge on the competition. You would think that the numbers would show increased market share by now.
Yes - you would like that they would show market share increase by now. But they do not.
Are you sure??? There was a lot of hype around the product releases as next generation innovations that were to give us an edge on the competition. You would think that the numbers would show increased market share by now.
This person must be joking. They can't be serious. name one product B&L Pharma has that is a next generation drug and zirgan doesn't count..
Besi is a me too FQ in a me too vehicle the docs don't want for post op.
steriods are 10 years old. I'm just not seeing the hype. All products are losing to generics or entrenched branded. Zirgan isn't being measured against all products in all classes that docs prescribe that med for. Congratulations, you have a 50% share of the narrowest market basket ever.
Omg people could you complain any more? Here is a thought, if you don't like your job QUIT! Of you don't like it here, leave. Find something else and quit your whining because it sure as shit isn't going to make adifference. So sick of you people, I swear.. Get a life. Could things be better, yes but feel with what you have or shut up! You are probably all bottom feeders anyways.
Are you sure??? There was a lot of hype around the product releases as next generation innovations that were to give us an edge on the competition. You would think that the numbers would show increased market share by now.